{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:50:23Z","timestamp":1793317823155,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Special Support Program of Sun Yat-sen University Cancer Center","award":["16zxtzlc06"],"award-info":[{"award-number":["16zxtzlc06"]}]},{"name":"Natural Science Foundation of Guang Dong Province","award":["2017A030312003"],"award-info":[{"award-number":["2017A030312003"]}]},{"name":"Health & Medical Collaborative Innovation Project of Guangzhou City","award":["201604020003"],"award-info":[{"award-number":["201604020003"]}]},{"name":"Health & Medical Collaborative Innovation Project of Guangzhou City","award":["201803040003"],"award-info":[{"award-number":["201803040003"]}]},{"name":"Innovation Team Development Plan of the Ministry of Education","award":["IRT_17R110"],"award-info":[{"award-number":["IRT_17R110"]}]},{"name":"Overseas Expertise Introduction Project for Discipline Innovation (111 Project)","award":["B14035"],"award-info":[{"award-number":["B14035"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.radonc.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:34:00Z","timestamp":1538037240000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis"],"prefix":"10.1016","volume":"129","author":[{"given":"Xiao-Dan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Wen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-2929","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.09.004_b0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2018.09.004_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","article-title":"Nasopharyngeal carcinoma incidence and mortality in China, 2013","volume":"36","author":"Wei","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2016.67.4119","article-title":"What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis","volume":"35","author":"Ribassin-Majed","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0035","unstructured":"National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. Head and Neck Cancer, Version 1. 2018. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed February 15, 2018."},{"key":"10.1016\/j.radonc.2018.09.004_b0040","series-title":"World report on ageing and health","author":"Beard","year":"2015"},{"key":"10.1016\/j.radonc.2018.09.004_b0045","series-title":"Competing risks: a practical perspective","author":"Pintilie","year":"2006"},{"key":"10.1016\/j.radonc.2018.09.004_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.21037\/atm.2017.07.27","article-title":"Nomogram for survival analysis in the presence of competing risks","volume":"5","author":"Zhongheng","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2018.09.004_b0055","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1200\/JCO.2015.65.0739","article-title":"Improved method to stratify elderly patients with cancer at risk for competing events","volume":"34","author":"Carmona","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaoncol.2017.4478","article-title":"Primary cancer vs competing causes of death in survivors of head and neck cancer","volume":"4","author":"Simpson","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JCO.2016.69.0834","article-title":"Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non\u2013small-cell lung cancer: a competing risks analysis","volume":"35","author":"Eguchi","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0070","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.7150\/jca.20081","article-title":"Decreased overall and cancer-specific mortality with neoadjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: multivariate competing risk analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO.2009.22.4816","article-title":"Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram","volume":"28","author":"Kutikov","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0080","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2012.42.4457","article-title":"Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer","volume":"31","author":"Yang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0085","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.eururo.2014.09.019","article-title":"Nomogram predicting prostate cancer\u2013specific mortality for men with biochemical recurrence after radical prostatectomy","volume":"67","author":"Brockman","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2018.09.004_b0090","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.cllc.2017.10.016","article-title":"Nomogram to predict cause-specific mortality in patients with surgically resected stage I non\u2013small-cell lung cancer: a competing risk analysis","volume":"19","author":"Zhou","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0095","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/cncr.30775","article-title":"Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: a large-scale, big-data intelligence platform\u2013based analysis from an endemic area","volume":"123","author":"Lv","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0100","series-title":"American joint committee on cancer staging manual","year":"2017"},{"key":"10.1016\/j.radonc.2018.09.004_b0105","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.radonc.2018.09.004_b0115","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma","volume":"24","author":"Leung","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0120","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma","volume":"108","author":"Tang","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.09.004_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oraloncology.2017.04.015","article-title":"Establishing and applying nomograms based on the 8th edition of the UICC\/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy","volume":"69","author":"Xu","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2407-13-226","article-title":"Influence of gender and age on the survival of patients with nasopharyngeal carcinoma","volume":"4","author":"Xiao","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.08.006","article-title":"Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: a population-based analysis","volume":"73","author":"Wu","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"Marengoni","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.radonc.2018.09.004_b0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2018.09.004_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0284186X.2012.742964","article-title":"The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database","volume":"52","author":"B\u00f8je","year":"2013","journal-title":"Acta Oncol."},{"key":"10.1016\/j.radonc.2018.09.004_b0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2014.12.002","article-title":"Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score model","volume":"114","author":"Guo","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0160","article-title":"Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2018.09.004_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach","volume":"55","author":"Janssen-Heijnen","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2018.09.004_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"22","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"key":"10.1016\/j.radonc.2018.09.004_b0175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2018.09.004_b0180","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/bjc.2015.70","article-title":"The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis","volume":"112","author":"OuYang","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2018.09.004_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdl320","article-title":"Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology","volume":"18","author":"Ou","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2018.09.004_b0190","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/j.ijrobp.2011.06.1967","article-title":"Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis","volume":"82","author":"Zhou","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401833487X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401833487X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:06:29Z","timestamp":1759122389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401833487X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S016781401833487X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.004","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}